{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T19:46:50Z","timestamp":1794944810218,"version":"4.9.1"},"reference-count":19,"publisher":"Cambridge University Press (CUP)","issue":"7","license":[{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Infect. Control Hosp. Epidemiol."],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec id=\"S0899823X2500090X_as1\"><jats:title>Background:<\/jats:title><jats:p>Broad-spectrum antibiotic use in febrile neutropenia is often driven by concerns for severe and drug-resistant infections. In select patients who do not have an active infection and improve, their prolonged and unnecessary use contributes to antimicrobial resistance, drug toxicity, and increased healthcare costs. We describe the implementation of an antibiotic de-escalation protocol to reduce inappropriate antibiotic use in febrile neutropenia among hematology patients.<\/jats:p><\/jats:sec><jats:sec id=\"S0899823X2500090X_as2\"><jats:title>Methods:<\/jats:title><jats:p>We conducted baseline analysis (January\u2013June 2024) of antibiotic use in febrile neutropenia cases admitted under hematology. Interventions included the (i) development of an antibiotic de-escalation protocol to guide clinical management, (ii) a roadshow to educate and improve uptake of this protocol, and (iii) regular feedback via \u201creport cards\u201d for hematology teams. The primary outcome was the proportion of febrile neutropenia cases with inappropriate antibiotic use, with secondary measures including adverse outcomes (in-hospital mortality, <jats:italic>Clostridioides difficile<\/jats:italic> infection, need for intensive care).<\/jats:p><\/jats:sec><jats:sec id=\"S0899823X2500090X_as3\"><jats:title>Results:<\/jats:title><jats:p>Baseline data indicated inappropriate antibiotic use rates of 45.5\u201366.7% per month from January to June 2024, with 13\u201328 days of inappropriate therapy. The protocol was developed in July 2024, with a subsequent roadshow to promote its uptake. Regular feedback was provided in the form of \u201creport cards\u201d every 2-monthly thereafter. Post-intervention, inappropriate antibiotic use decreased to a median of 23.35% from July to December 2024, with no observed increase in adverse outcomes.<\/jats:p><\/jats:sec><jats:sec id=\"S0899823X2500090X_as4\"><jats:title>Conclusions:<\/jats:title><jats:p>The implementation of a structured de-escalation protocol, combined with frequent education and feedback, effectively reduced inappropriate antibiotic use in febrile neutropenia without compromising patient safety.<\/jats:p><\/jats:sec>","DOI":"10.1017\/ice.2025.90","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T04:11:48Z","timestamp":1747368708000},"page":"747-752","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":3,"title":["Reducing inappropriate antibiotic use in febrile neutropenia in hematology patients through the implementation of an antibiotic de-escalation protocol"],"prefix":"10.1017","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3339-7281","authenticated-orcid":false,"given":"Jinghao Nicholas","family":"Ngiam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7374-8207","authenticated-orcid":false,"given":"Matthew Chung Yi","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Nasar Fathima Rofina","family":"Farveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0050-9988","authenticated-orcid":false,"given":"Shi Hui Clarice","family":"Choong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li Mei Michelle","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang Piu","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1308-5977","authenticated-orcid":false,"given":"Nares","family":"Smitasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel Hon-Wai","family":"Lum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2025,5,16]]},"reference":[{"key":"S0899823X2500090X_ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-80163-1"},{"key":"S0899823X2500090X_ref18","first-page":"181","article-title":"Duration of antibiotic therapy for common infections","volume":"6","author":"Grant","year":"2021","journal-title":"J Assoc Med Microbiol Infect Dis Can"},{"key":"S0899823X2500090X_ref1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.091025"},{"key":"S0899823X2500090X_ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2024.07.020"},{"key":"S0899823X2500090X_ref6","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2019.1573670"},{"key":"S0899823X2500090X_ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2017.09.030"},{"key":"S0899823X2500090X_ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70344-4"},{"key":"S0899823X2500090X_ref12","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000004698"},{"key":"S0899823X2500090X_ref15","first-page":"CD012184","article-title":"Early discontinuation of antibiotics for febrile neutropenia versus continuation until neutropenia resolution in people with cancer","volume":"1","author":"Stern","year":"2019","journal-title":"Cochrane Database Syst Rev."},{"key":"S0899823X2500090X_ref16","doi-asserted-by":"publisher","DOI":"10.1080\/23744235.2018.1438649"},{"key":"S0899823X2500090X_ref13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150795"},{"key":"S0899823X2500090X_ref17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.02224"},{"key":"S0899823X2500090X_ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmedinf.2023.105205"},{"key":"S0899823X2500090X_ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-020-0811-y"},{"key":"S0899823X2500090X_ref7","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae487"},{"key":"S0899823X2500090X_ref14","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkae199"},{"key":"S0899823X2500090X_ref9","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkad166"},{"key":"S0899823X2500090X_ref4","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw459"},{"key":"S0899823X2500090X_ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-018-3328-1"}],"container-title":["Infection Control &amp; Hospital Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0899823X2500090X","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T08:21:22Z","timestamp":1752826882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0899823X2500090X\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0899823X2500090X"],"URL":"https:\/\/doi.org\/10.1017\/ice.2025.90","relation":{},"ISSN":["0899-823X","1559-6834"],"issn-type":[{"value":"0899-823X","type":"print"},{"value":"1559-6834","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,16]]},"assertion":[{"value":"\u00a9 The Author(s), 2025. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https:\/\/creativecommons.org\/licenses\/by\/4.0\/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}